NDC properties for "Zanosar 1 GM Injection" (RxCUI 207948)
About this data
The tables show NDC propoerties for Zanosar 1 GM Injection with the RxCUI 207948
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product
Details for Zanosar 1 GM Injection (RxCUI 207948)
| MMSL_CODE | BD2914 |
|---|---|
| NDA | NDA050577 |
| RxCUI | 207948 |
| SPL_SET_ID | 15d161ed-9e7b-4c92-ba45-0556d2423e67 |
| SPL_SET_ID | f31d3bff-6fc6-c35f-e053-2995a90a596b |
| Prescribable Synonym | Zanosar 1 GM Injection |
| RXNAV_STR | Zanosar 1 GM Injection |
| RxNorm Name | streptozocin 1000 MG Injection [Zanosar] |
| RxNorm Synonym | Zanosar 1 GM Injection |
| RxNorm Synonym | Zanosar 1000 MG Injection |
| Related queries | Interactions (for RxCUI 207948) |
NDC Properties
NDC Item 00703463601
| NDC 9 | 0703-4636 |
|---|---|
| NDC 10 | 0703-4636-01 |
| NDC Item | 00703463601 |
| Packaging | 10 mL in 1 VIAL (0703-4636-01) |
| FDA SPL set id | 717032 |
| Labeler | Teva Parenteral Medicines, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-12-03 |
| Marketing status | ACTIVE |
| NDA | NDA050577 |
| Related queries | Properties for NDC 9 0703-4636 |
NDC Item 26060953004
| NDC 9 | 26060-9530 |
|---|---|
| NDC 10 | 26060-9530-4 |
| NDC Item | 26060953004 |
| Related queries | Properties for NDC 9 26060-9530 |
NDC Item 68118010001
| NDC 9 | 68118-100 |
|---|---|
| NDC 10 | 68118-100-01 |
| NDC Item | 68118010001 |
| Packaging | 1 VIAL, GLASS in 1 CARTON (68118-100-01) / 10 mL in 1 VIAL, GLASS |
| FDA SPL set id | 704547 |
| Labeler | ESTEVE PHARMACEUTICALS, S.A. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_FOR_USE_IN_DRUG_SHORTAGE | N/A |
| Related queries | Properties for NDC 9 68118-100 |
NDC Item 00703463601
| NDC 9 | 0703-4636 |
|---|---|
| NDC 10 | 0703-4636-01 |
| NDC Item | 00703463601 |
| Packaging | 10 mL in 1 VIAL (0703-4636-01) |
| FDA SPL set id | 717032 |
| Labeler | Teva Parenteral Medicines, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-12-03 |
| Marketing status | ACTIVE |
| NDA | NDA050577 |
| Related queries | Properties for NDC 9 0703-4636 |
NDC Item 26060953004
| NDC 9 | 26060-9530 |
|---|---|
| NDC 10 | 26060-9530-4 |
| NDC Item | 26060953004 |
| Related queries | Properties for NDC 9 26060-9530 |
NDC Item 68118010001
| NDC 9 | 68118-100 |
|---|---|
| NDC 10 | 68118-100-01 |
| NDC Item | 68118010001 |
| Packaging | 1 VIAL, GLASS in 1 CARTON (68118-100-01) / 10 mL in 1 VIAL, GLASS |
| FDA SPL set id | 704547 |
| Labeler | ESTEVE PHARMACEUTICALS, S.A. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_FOR_USE_IN_DRUG_SHORTAGE | N/A |
| Related queries | Properties for NDC 9 68118-100 |
NDC Item 00703463601
| NDC 9 | 0703-4636 |
|---|---|
| NDC 10 | 0703-4636-01 |
| NDC Item | 00703463601 |
| Packaging | 10 mL in 1 VIAL (0703-4636-01) |
| FDA SPL set id | 717032 |
| Labeler | Teva Parenteral Medicines, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2003-12-03 |
| Marketing status | ACTIVE |
| NDA | NDA050577 |
| Related queries | Properties for NDC 9 0703-4636 |
NDC Item 26060953004
| NDC 9 | 26060-9530 |
|---|---|
| NDC 10 | 26060-9530-4 |
| NDC Item | 26060953004 |
| Related queries | Properties for NDC 9 26060-9530 |
NDC Item 68118010001
| NDC 9 | 68118-100 |
|---|---|
| NDC 10 | 68118-100-01 |
| NDC Item | 68118010001 |
| Packaging | 1 VIAL, GLASS in 1 CARTON (68118-100-01) / 10 mL in 1 VIAL, GLASS |
| FDA SPL set id | 704547 |
| Labeler | ESTEVE PHARMACEUTICALS, S.A. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Marketing effective time low | 2023-02-01 |
| Marketing status | ACTIVE |
| UNAPPROVED_DRUG_FOR_USE_IN_DRUG_SHORTAGE | N/A |
| Related queries | Properties for NDC 9 68118-100 |